Ministry of Commerce: steady growth of actual foreign investment in January 2020
According to the Ministry of Commerce on February 17, China's absorption of foreign investment in January 2020 was released today. In January this year, the actual use of foreign investment maintained a steady growth. There were 3485 newly established foreign-funded enterprises in China. The actual use of foreign investment was 87.57 billion yuan, up 4% year-on-year (US $12.68 billion, up 2.2% year-on-year, excluding data in the fields of banking, securities and insurance, the same below), basically continuing the steady growth momentum since last year. The absorption of foreign investment by high-tech industries continued to maintain a high growth rate in January. The actual use of foreign investment by high-tech industries reached RMB 31.35 billion, an increase of 27.9% year on year, accounting for 35.8%. The actual use of foreign investment in high-tech manufacturing industry is 8.4 billion yuan, of which the actual use of foreign investment in pharmaceutical manufacturing industry, medical equipment and instrument manufacturing industry increased by 10.5% and 118.9% respectively year on year. The actual use of foreign investment in high-tech service industry was 22.95 billion yuan, up 45.5% year on year. Among them, the actual use of foreign investment in information services, R & D and design services increased by 56.6% and 39.2% year-on-year respectively. Three, one belt, one road, the main source of investment, Singapore, Korea and Japan increased 40.6%, 157.1% and 50.2% respectively. The investment in foreign countries along the belt and road has increased by 31.3% and 44.8% respectively (including data from free port).
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
Ibuprofen API Giant to Expand Capacity by 50%, Annual Capacity to Reach 18,000 Tonnes
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
LB Group Accelerates Overseas Investment: Securing Mines in Western Australia and Building a Plant in Malaysia
-
Nitrogen’s Quiet Powerhouse: CF Industries Delivers Record Profit Amid Global Food Security Shift
-
From Recovery to Roaring: Mosaic’s Q3 2025 Delivers Triple-Digit Profit Surge on Fertilizer Resurgence
-
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
Recommend Reading
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Methanol Market Prices Undergo Slight Adjustment
-
Acetic Acid Market Prices Narrowly Consolidate
-
This Week's Aniline Market Remains Stable at High Levels (2.9-2.13) in China
-
Strong Ethanol Market Performance in China
-
BDO Market Prices Consolidate in a Narrow Range
- Hot Searches
- di ammonium phosphate price
- kerosene prices near me today
- buy sodium nitrite
- glp-3 retatrutide buy online usa
- where to buy cerebrolysin
- butane price
- retatrutide supplier china
- ethylhexyl triazone wikipedia
- where to buy anhydrous ammonia
- where to get reta peptide
- dichloromethane sds
- retatrutide supplier china